NPI: 1043277015 · MIAMI GARDENS, FL 33056 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/26/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/26/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 19,157 | $3.27M |
| 2019 | 24,107 | $4.61M |
| 2020 | 23,735 | $4.33M |
| 2021 | 14,456 | $1.26M |
| 2022 | 10,279 | $1.52M |
| 2023 | 1,176 | $307K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 26,815 | 1,830 | $4.77M |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 29,440 | 1,398 | $4.46M |
| J1270 | Injection, doxercalciferol, 1 mcg | 20,805 | 1,424 | $3.13M |
| A4657 | Syringe, with or without needle, each | 4,419 | 1,447 | $886K |
| J1756 | Injection, iron sucrose, 1 mg | 3,467 | 845 | $477K |
| 82728 | 1,149 | 808 | $245K | |
| 83970 | 1,301 | 829 | $244K | |
| 85041 | 1,356 | 956 | $242K | |
| 85048 | 1,342 | 952 | $241K | |
| 83540 | 1,140 | 805 | $228K | |
| 83550 | 963 | 676 | $204K | |
| J0604 | Cinacalcet, oral, 1 mg, (for esrd on dialysis) | 441 | 214 | $114K |
| 90674 | 58 | 46 | $21K | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 86 | 58 | $18K |
| G0008 | Administration of influenza virus vaccine | 63 | 47 | $16K |
| 82108 | 35 | 25 | $9K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 30 | 13 | $3K |